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Introduction
Although Polymyxin-B hemoperfusion (PMX-HP) is
supposed to improve outcomes in patients with sepsis in
adsorbing endotoxin and decreasing systemic inflamma-
tion, the recent ABDOMIX study did not demonstrate
any beneficial effect of PMX-HP in patients with septic
shock due to peritonitis [1]. In this context, cytokine
clearance induced by PMX-HP is debated.
Objectives
To assess the influence of PMX-HP on plasma cytokine
concentrations and to identify cytokines associated with
day 28 mortality.
Methods
This ancillary study of the ABDOMIX study investigated
the impact of two PMX-HP sessions on day 28 mortality
in peritonitis-induced septic shock, blood samples were
performed within 10 hours post-surgery (P1), at the end
of the first hemoperfusion session in the experimental
group or 2 hours after P1 in the control group (P2), 24
hours after P1 (P3), and at the end of the second hemo-
perfusion session in the experimental group or 2 hours
after P3 in the control group (P4). Cytokines such as
Tumor Necrosis Factor a, Interferon (IFN) g, Interleu-
kin (IL) 1b, IL-1a, IL-1RA, IL-6, IL-4, IL-10, IL-17A
and IL-22 were assessed using magnetic bead-based
immunology multiplex assay or enzyme-linked immuno-
sorbent assay.
Results
Among the 232 patients included in the ABDOMIX
study, 19 patients were excluded due to missing sam-
pling and therefore 213 patients (109 in the hemoperfu-
sion group and 104 in the control group) were included
in the analysis. Post-operative P1 cytokine concentra-
tions were not different between the 2 groups. Cytokines
variation between P1 and P2 were not different between
the 2 groups except for IL-1RA and IL-10 which
decreased more in the control group than in the hemo-
perfusion group (p = 0.016 and 0.047, respectively).
Cytokines variations between P3 and P4 were not differ-
ent between the 2 groups except for IL-10 and IL-22
which both decreased in the control group whereas both
increased in the hemoperfusion group (p = 0.002 and
0.04, respectively). Using a logistic stepwise regression
model, the absence of decrease in IL-10 and IL-22
between P1 and P3 were associated with day 28 mortal-
ity independently from Simplified Acute Physiology
Score II (p = 0.002 and 0.04, respectively).
Conclusions
PMX-HP was not associated with a decrease in cytokines
concentrations as compared to control group. Higher
levels of IL-10 and IL-22 in PMX-HP group may suggest
unexpected deleterious interference between these cyto-
kines and polymyxin-B membrane. The absence of
decrease in IL-10 or IL-22 blood concentrations within
24 hours after peritonitis-related septic shock was inde-
pendently associated with day 28 mortality.
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